LCTX•benzinga•
B. Riley Securities Maintains Buy on Lineage Cell Therapeutics, Lowers Price Target to $3
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 14, 2025 by benzinga